Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-28Clinical Trial Update: Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department [Phase 4]
A Phase 4 pilot trial of BXCL501 (sublingual dexmedetomidine) for agitation in the emergency department, including schizophrenia-spectrum an…
-
CLINICAL_TRIALS withdrawal · 2025-04-08Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 trial evaluating the safety and tolerability of Lyndra's long-acting oral risperidone (LYN-005) in schizophrenia or schizoaffectiv…
-
CLINICAL_TRIALS withdrawal · 2024-06-24Clinical Trial Update: An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms [NA]
The UCLA-sponsored open-label, single-arm trial of amisulpride for treatment-resistant schizophrenia and schizoaffective disorder has been w…
-
CLINICAL_TRIALS withdrawal · 2018-04-05Clinical Trial Update: Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia [Phase 4]
The Phase 4 clinical trial examining clonazepam effects on brain oscillations and cognition in schizophrenia-related conditions has been wit…
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia [NA]
A clinical trial evaluating transcranial direct current stimulation for hallucinations in first-episode schizophrenia has been withdrawn fro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-11-29Clinical Trial Update: Safety and Tolerability of Varenicline in Schizophrenia (SATOVA) [Phase 4]
A Phase 4 trial evaluating the safety and tolerability of varenicline in schizophrenia and schizoaffective disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia [Phase 2]
A Phase 2 trial evaluating targeted Vitamin D treatment for schizophrenia-associated hyperprolinemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-31Clinical Trial Update: Cardio Risk of Acute Schizophrenia Olanzapine Duke [Phase 4]
A Phase 4 clinical trial evaluating cardiac risk with olanzapine in acute schizophrenia/schizoaffective disorder was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-12-23Clinical Trial Update: Zyprexa and Task Engagement in Schizophrenia [Phase 3]
A Phase 3 trial evaluating Zyprexa (olanzapine) for task engagement in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-06-29Clinical Trial Update: Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients [Phase 3]
Phase 3 trial evaluating bexarotene and fenretinide as add-on therapy to antipsychotics in schizophrenia and schizoaffective disorder has be…